Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Cancer Research
|
March 1, 1981
Comparative study of two groups of inducers of Friend erythroleukemia cell differentiation in a chemically defined medium
Y Gazitt
Cancer Research
|
July 1, 1981
Inhibition of induced L-ornithine decarboxylase stimulation and erythrodifferentiation in Friend erythroleukemia cells by 2',5'-isoadenylate trimer core
Y Gazitt
Leukemia
|
November 11, 1999
TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells
Y Gazitt
Leukemia
|
October 24, 2003
Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and antilineage-specific antibodies
Y Gazitt
Journal of Hematotherapy & Stem Cell Research
|
May 22, 2001
Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules
Y Gazitt
Stem Cells (Dayton, Ohio)
|
November 10, 2000
Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors
Y Gazitt
Journal of Cellular Physiology
|
June 1, 1979
Early decrease of 2-deoxy glucose and alpha-amino isobutyric acid transport are among the first events in differentiating synchronized murine erythroleukemia cells
Y Gazitt
Cancer Research
|
March 1, 1981
Synthesis and phosphorylation of plasma membrane proteins of Friend erythroleukemia cells induced to differentiate
Y Gazitt, C Friend
Cancer Research
|
March 1, 1981
Early and late changes in the glycoproteins of Friend erythroleukemia cells induced to differentiate
Y Gazitt, C Friend
Oncology Reports
|
May 19, 2011
Pitfalls in the RNA-based PCR amplification of the CDRIII sequence for quantitation of minimal residual disease in multiple myeloma (Commentary)
Y Gazitt, S Hilsenbeck
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Cancer Research
|
March 1, 1981
Comparative study of two groups of inducers of Friend erythroleukemia cell differentiation in a chemically defined medium
Y Gazitt
Cancer Research
|
July 1, 1981
Inhibition of induced L-ornithine decarboxylase stimulation and erythrodifferentiation in Friend erythroleukemia cells by 2',5'-isoadenylate trimer core
Y Gazitt
Leukemia
|
November 11, 1999
TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells
Y Gazitt
Leukemia
|
October 24, 2003
Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and antilineage-specific antibodies
Y Gazitt
Journal of Hematotherapy & Stem Cell Research
|
May 22, 2001
Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules
Y Gazitt
Stem Cells (Dayton, Ohio)
|
November 10, 2000
Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors
Y Gazitt
Journal of Cellular Physiology
|
June 1, 1979
Early decrease of 2-deoxy glucose and alpha-amino isobutyric acid transport are among the first events in differentiating synchronized murine erythroleukemia cells
Y Gazitt
Cancer Research
|
March 1, 1981
Synthesis and phosphorylation of plasma membrane proteins of Friend erythroleukemia cells induced to differentiate
Y Gazitt, C Friend
Cancer Research
|
March 1, 1981
Early and late changes in the glycoproteins of Friend erythroleukemia cells induced to differentiate
Y Gazitt, C Friend
Oncology Reports
|
May 19, 2011
Pitfalls in the RNA-based PCR amplification of the CDRIII sequence for quantitation of minimal residual disease in multiple myeloma (Commentary)
Y Gazitt, S Hilsenbeck
Page
of 10